brookings - Post a comment [entries|archive|friends|userinfo]
brookings

[ userinfo | sc userinfo ]
[ archive | journal archive ]

Sep. 1st, 2016|11:11 am

watt
nu, nu izstāsti smalkāk šo peļņa pret vērtību pozīciju. skat, piemēram ja vērtība ir tavas (slimnieka) dzīvības saglabāšana:

" insulin which "in 2001 had the wholesale price of $45. By last year, the cost had skyrocketed to $1,447" for the same monthly supply"
http://mtstandard.com/news/local/insulin-price-spike-leaves-diabetes-patients-in-crisis/article_74cd6b23-7d9d-5f36-9df0-9c72c5de9f1a.html


"A two pack EpiPen now costs about $600. The device, however, was not always this costly. The price was only about $100 in 2008, but this has since increased by more than 450 percent."
"Mylan pharmaceutical, the company behind the product, said that EpiPen's increasing prices "reflect important product features and the value the product provides."
http://www.techtimes.com/articles/174396/20160820/epipen-price-skyrockets-what-is-epipen-why-is-it-so-expensive-and-where-can-we-get-cheaper-alternative.htm

"Epinephrine is very, very cheap. Even in the developing world, it costs less than a dollar per milliliter,"
"The EpiPen isn’t new; it has been in use since 1977. Research and development costs were recouped long ago. Nine years ago, it was bought by the pharmaceutical company Mylan, which then began to sell the device. When Mylan bought it, EpiPens cost about $57 each."
http://www.nytimes.com/2016/08/24/upshot/the-epipen-a-case-study-in-health-care-system-dysfunction.html
link Read Comments

Reply:
From:
( )Anonymous- this user has disabled anonymous posting.
Username:
Password:
Subject:
No HTML allowed in subject
  
Message: